What you'll learn

  • Select “appropriate” hemostatic therapy for patients presenting with acute, life-threatening hemorrhage associated with oral anticoagulation
  • Identify options and limitations for appropriate hemostatic therapy for patients requiring emergent surgery while on factor Xa inhibitors based on different patient specific and surgery specific factors
  • Develop clinical pathways for efficient use of hemostatic agents in the setting of anticoagulation reversal based on bleed location and severity as well as laboratory parameters

Course description

This is an accredited, livestreamed course offered by Harvard Medical School as part of the Contemporary Pharmacotherapy: Collaborative Clinical Explorations series. This course is targeted to pharmacists, pharmacy residents, physicians, physician assistants, clinicians, medical residents, nurses and nurse practitioners.

Select the Take Course button to view additional information on the course registration page.

Contact ceprograms@hms.harvard.edu with questions.

*Register before September 24 to receive the discounted price.

Associated Schools

  • Harvard Medical School

Enroll now.
Learn More